Centre for Epidemiological Modelling and Analysis (CEMA), have released results of three studies that could significantly ...

Findings from Kenya by CEMA at the International AIDS Society Conference on HIV ScienceRwanda, July 15, 2025-- The University of Nairobi, Center for Epidemiological Modelling and Analysis (CEMA), has ...

KUCHING: Asean member states must work together to reduce the cost of next-generation antiretroviral (ARV) drugs for HIV ...

KUCHING: Asean must work together to reduce the cost of next-generation antiretroviral (ARV) drugs for HIV patients in their respective countries, says Datuk Lukanisman Awang Sauni.

Experts have proposed new treatment modes for older people with HIV. The new treatment does not cause the health-threatening ...

Researchers found that lenacapavir reduced almost 100% reduction new HIV infections among participants who received it as a ...

ViiV Healthcare, the HIV-focused joint venture majority owned by GSK , said on Monday it has expanded its licensing deal with ...

An investigational once-weekly oral antiretroviral therapy (ART) combination effectively maintained viral suppression in ...

The World Health Organization is now recommending that countries include an HIV drug newly approved for prevention, ...

In a phase 2 trial, an antiretroviral combination developed by Gilead Sciences and MSD suppressed HIV with a single weekly oral dose, raising the hope of a new treatment option for patients. The ...

Utah biochemist Wesley Sundquist has achieved yet another milestone with the Food and Drug Administration approval of an antiviral drug for HIV prevention based on his findings.